ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life and rheumatoid arthritis (RA)"

  • Abstract Number: 296 • 2018 ACR/ARHP Annual Meeting

    Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study

    Manjari Lahiri1,2, Peter P.M. Cheung1,2, Preeti Dhanasekaran2, Su Ren Wong3, Ai Yap3, Daphne Tan3, Amelia Santosa1,2 and Phillip HC Phan2, 1Division of Rheumatology, University Medicine Cluster, National University Hospital, Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 3Department of Rehabilitation, National University Hospital, Singapore, Singapore, Singapore

    Background/Purpose: Quality standards recommend an annual review by a multidisciplinary team (MDT) for all patients with rheumatoid arthritis (RA); however, this is based on expert…
  • Abstract Number: 349 • 2018 ACR/ARHP Annual Meeting

    Improving the Performance of the Spanish Version of QOL-RA

    Carolina Ayelen Isnardi1, Dafne Capelusnik2, Emilce E Schneeberger3, María de los Angeles Correa4, Romina Lim5, María Hu5, María Janina Tapia6, Eduardo Mario Kerzberg7, Eliana Soledad Blanco8, Federico Lujan Benavidez8, Luciana Gonzalez Lucero9, Ana Lucia Barbaglia9, Marcela Bazzarelli10, Hernán Maldonado Ficco11, Silvana Karina Pérez12, Claudia Hartvig13, Mariana Salcedo14 and Gustavo Citera15, 1Reumatology, Instituto de Rehabilitación Psicofísica, CABA, Argentina, 2Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, 3Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Reumatology, Hospital Penna, CABA, Argentina, 6Reumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, 7Department of Rheumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, 8Reumatology, Hospital General de Agudos Dr. Cosme Argerich, CABA, Argentina, 9Hospital Angel C. Padilla, Tucuman, Argentina, 10Reumatology, Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina, 11Rheumatology Section, Hospital San Antonio de Padua, Río Cuarto- Córdoba, Argentina, 12Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, CABA, Argentina, 13Rheumatology Section, Hospital Provincial de Rosario, Rosario-Santa Fe, Argentina, 14Reumatology, San Nicolás, Buenos Aires, Argentina, 15Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina

    Background/Purpose: We have recently validated the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA). Redundancy between questions Nº 3 and Nº 6 was observed, and it was…
  • Abstract Number: 1387 • 2018 ACR/ARHP Annual Meeting

    Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients

    Jens Gert Kuipers1, Michael Koller2, Ulrich Rueffer3, Florian Zeman2, Karolina Mueller4 and Joachim Weis5, 1Clinic for Internal Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3German Fatigue Society, Cologne, Germany, 4Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 5University Clinic Centre Freiburg, Freiburg, Germany

    Background/Purpose: Fatigue is a common symptom in patients with rheumatoid arthritis (RA) as well as patients with cancer. Fatigue considerably reduces the quality of life…
  • Abstract Number: 1525 • 2018 ACR/ARHP Annual Meeting

    Effect of JAK-Inhibitor Versus Bdmards on Quality of Life in Rheumatoid Arthritis : A Meta Analysis of Randomized Controlled Trials

    Mamadaly Boudhabhay1, Thomas Barnetche2 and Pascale Vergne-Salle3, 1CHU de Limoges, Limoges, France, 2Rheumatology Department, FHU ACRONIM, Bordeaux University Hospital, Bordeaux, France, 3Rheumatology, CHU de Limoges, Limoges, France

    Background/Purpose: Recent studies comparing JAK-inhibitors (Jak-i) and adalimumab seem to show a better efficacy of JAK-i on patient-reported outcomes in rheumatoid arthritis (RA). As there…
  • Abstract Number: 1555 • 2018 ACR/ARHP Annual Meeting

    Quality of Life of Rheumatoid Arthritis Patients Treated with Biologics

    Sonia Tropé1, Gérard Thibaud2, Françoise Alliot3, Didier Formont4 and Sadek Krouri5, 1149 avenue du Maine, ANDAR, Paris, France, 2ANDAR patient organisation, Paris, France, 3AFLAR, Paris, France, 4A+A Healthcare Market Research, BOULOGNE, France, 5Public affair & Advocacy Rheumatology, Sanofi, Gentilly, France

    Background/Purpose: Major advances in the management of rheumatoid arthritis (RA) have been recorded over the last decade thanks to the introduction of biologics. However, medical…
  • Abstract Number: 2482 • 2018 ACR/ARHP Annual Meeting

    The Use of Any Conventional Synthetic DMARD Is Associated with Better Indexes of the Physical Component Evaluated By 12-Item Short-Form Health Survey : Analysis of a Cohort of RA Patients

    Alisson Pugliesi1, Eduardo de Almeida Macedo2, Manoel Barros Bertolo3, Rina Dalva Neubarth Giorgi4, Sebastião Radominski5, Ivânio Alves Pereira6, Maria Fernanda Brandao de Resende Guimarães7, Paulo Louzada Junior8, Maria de Fátima da Cunha Sauma9, Karina Bonfiglioli10, Claiton Brenol11, Lícia M. H. Mota12 and Geraldo Castelar Pinheiro13, 1INTERNAL MEDICINE, DISCIPLINE OF RHEUMATOLOGY, University of Campinas (UNICAMP), CAMPINAS, Brazil, 2Internal Medicine, University of Campinas (UNICAMP), Campinas, Brazil, 3University of Campinas (UNICAMP), Campinas, Brazil, 4Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil, 5Unversidade Federal do Paraná, Curitiba, Brazil, 6Universidade Federal de Santa Catarina, Florianópolis, Brazil, 7Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 8Universidade de São Paulo - Ribeirão Preto, Ribeirão Preto, Brazil, 9Universdade Federal do Pará, Belém, Brazil, 10Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 11Rua Cabral, 764 – Apto 302, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 12Hospital Universitário de Brasília - UnB, Brasília, Brazil, 13Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    Background/Purpose: Patients with rheumatoid arthritis (RA) report a reduction in quality of life (QoL) in several aspects when compared to the healthy population. QoL can…
  • Abstract Number: PP04 • 2018 ACR/ARHP Annual Meeting

    Improved Quality of Life with Patient Engagement in Research

    Kelly English1 and Graham Macdonald2, 1Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, 2Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada

    Background/Diagnosis: I am a woman, 60 years old who has lived with difficult-to-treat Rheumatoid Arthritis for 23 years. When first  diagnosed with RA, there were…
  • Abstract Number: 2220 • 2017 ACR/ARHP Annual Meeting

    Neuropathic-like Pain Affects the Tender Joint Count and Health-Related Quality of Life in Patients with Rheumatoid Arthritis

    Kentaro Noda1, Miku Tajima2, Yosuke Oto3, Kazuhiro Otani3, Yoshiga Masayuki3, Haruyasu Ito1, Ken Yoshida1 and Daitaro Kurosaka1, 1Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medecine, Jikei University School of Medicine, Tokyo, Japan, 3Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

    Background/Purpose: Pain in rheumatoid arthritis (RA) has been thought to be due to nociceptive pain, but it was reported recently to include a mechanism associated…
  • Abstract Number: 2244 • 2017 ACR/ARHP Annual Meeting

    Can Achieving Remission Improve Work Ability and Quality of Life in Early Rheumatoid Arthritis (RA) Patients? a Prospective Cohort Study

    Ho Man Lam1, Tsz Ho CHENG2 and Lai-Shan Tam1, 1Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: RA patients often suffer from impaired work ability and reduced health related quality of life (HRQoL). Whether achieving remission through tight-control treatment strategy using…
  • Abstract Number: 2254 • 2017 ACR/ARHP Annual Meeting

    Disability (HAQ) and Quality of Life (SF-12) As Related to Adherence and Health Literacyin Patients with Rheumatoid Arthritis – the Trace-Study

    Jens Gert Kuipers1, Michael Koller2, Florian Zeman2, Karolina Mueller2 and Jens Ulrich Rueffer3, 1Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2University Hospital Regensburg, Center for Clinical Studies, Regensburg, Germany, 3German Fatigue Society, Cologne, Germany

    Background/Purpose: Disabilities in daily living and quality of life are key endpoints to evaluate the outcome of treatment for rheumatoid arthritis (RA). Among factors that…
  • Abstract Number: 377 • 2016 ACR/ARHP Annual Meeting

    Pain and Quality of Life Profiles in Colombian Patients with Rheumatoid Arthritis: A Mixed Cluster Analysis

    Juan Manuel Cotte1, Nicolás Molano-González2, Deisy Hernández-Parra3, Yenifer Delgado-Scarpetta3, Adriana Rojas-Villarraga2, Juan-Manuel Anaya1 and Ricardo Pineda-Tamayo3, 1Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá, Colombia, 2Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá D.C., Colombia, 3Artmédica IPS, Medellin, Colombia, Medellin, Colombia

    ABSTRACT Background/Purpose: Among the symptoms of Rheumatoid Arthritis (RA), pain is often regarded as a critical factor related to quality of life (QoL) by patients,…
  • Abstract Number: 531 • 2016 ACR/ARHP Annual Meeting

    Disease Activity and Physical Fatigue As Related to Adherence and Health Literacy in Patients with Rheumatoid Arthritis

    Jens Gert Kuipers1, Michael Koller2, Florian Zeman2, Karolina Mueller3 and Ulrich Rueffer4, 1Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 4German Fatigue Society, Cologne, Germany

    Disease activity and physical fatigue as related to adherence and health literacy in patients with rheumatoid arthritis J. G. Kuipers1, M. Koller2, F. Zeman2, K.…
  • Abstract Number: 642 • 2016 ACR/ARHP Annual Meeting

    Quality of Life Outcomes Following Therapy with Chs-0214 and Etanercept (Enbrel): Randomized, Double-Blind Study in Subjects with Rheumatoid Arthritis

    Alan J. Kivitz1,2, James R. O'Dell3, Tsutomu Takeuchi4, Yoshiya Tanaka5, Satoshi Nakashima6, Cass Kelleher7, Jennifer Hodge8, Barbara Finck7 and RApsody Study Group, 1Altoona Center for Clinical Research, Duncansville, PA, 2Altoona Arthritis & Osteoporosis Center, Duncansville, PA, 3Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 4Division of Rheumatology, Department of Internal Medicine,, Keio University School of Medicine, Tokyo, Japan, 5The First Department of Internal Medicine,, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 6Daiishi Sankyo, Shinagawa-Ku Tokyo, Japan, 7Clinical Science, Coherus BioSciences, Redwood City, CA, 8Coherus BioSciences, Redwood City, CA

    Background/Purpose:  CHS-0214 is in development as a proposed biosimilar of etanercept. This Phase III confirmatory, safety and efficacy study randomized and dosed 644 subjects with…
  • Abstract Number: 1158 • 2016 ACR/ARHP Annual Meeting

    Effects of an Educational Program Using Treat to Target Strategy in Korean Patients with  Rheumatoid Arthritis

    SeungIn Paek1, Seo Hwa Kim2, Haneul Kim3, Min Kyung Chung4, Jennifer Lee5, Seung-Ki Kwok6, Ji Hyeon Ju7, Sung-Hwan Park7 and Kyeong Yae Sohng8, 1Center for Rheumatic Diseases, Seoul ST Mary's Hospital, The Catholic University of Korea, Seoul, South Korea, 2Division of Rheumatology,, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, 3Division of Rheumatology,, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Republic of Korea, Seoul, Korea, The Republic of, 4Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, 5Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 6[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 7Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 8College of Nursing, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose: The purpose of this study was to investigate the effects of an educational program using T2T (Treat RA to Target, T2T) strategy on Korean…
  • Abstract Number: 1231 • 2016 ACR/ARHP Annual Meeting

    Impact of Comorbidity on Health-Related Quality of Life and Healthcare Expenditure in Patients with Rheumatoid Arthritis

    Eric Nyarko1 and J An2, 1College of Pharmacy, Western University of Health Sciences, Pomona, CA, 2Western University of Health Sciences, Pomona, CA

    Background/Purpose: Rheumatoid Arthritis (RA) is known to be associated with an increased risk of comorbidity, premature mortality, and disability. We investigated the effect of comorbidity…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology